ACAD
32.21
+0.33
+1.05%
AEMD
0.27
+0.01
+4.83%
APRI
1.22
0.00
0.00%
ARNA
4.65
+0.1
+2.09%
ATEC
1.35
-0.02
-1.46%
CFN
59.8
+0.03
+0.05%
CNAT
5.74
+0.4
+7.49%
CRXM
0.2
0.00
-1.00%
CYTX
0.49
+0.01
+1.69%
DXCM
62.7
+4.76
+8.22%
GNMK
13.22
+0.07
+0.49%
HALO
14.42
+0.55
+3.97%
ILMN
201.52
+4.36
+2.21%
INNV
0.23
-0.02
-9.96%
INO
8.85
+0.24
+2.79%
ISCO
0.06
0.00
-1.67%
ISIS
72.86
+1.58
+2.22%
LGND
55.96
+1.29
+2.36%
LPTN
2.97
+0.01
+0.34%
MBVX
1.17
+0.03
+2.63%
MEIP
3.72
+0.03
+0.81%
MNOV
3.58
+0.03
+0.85%
MRTX
20
+0.73
+3.79%
MSTX
0.46
-0.01
-3.17%
NBIX
33.49
+1.79
+5.65%
NUVA
46.83
+0.07
+0.15%
ONCS
0.4
0.00
-0.50%
ONVO
6.74
+0.42
+6.65%
OREX
5.57
+0.16
+2.96%
OTIC
31.82
-1.12
-3.39%
QDEL
24.68
+0.36
+1.48%
RCPT
115.93
+5.83
+5.30%
RGLS
19.42
+0.88
+4.75%
RMD
67.16
+1.92
+2.94%
SCIE
0.01
0.00
0.00%
SPHS
0.46
0.00
-1.07%
SRNE
10.61
+0.64
+6.42%
TROV
5.93
+0.13
+2.24%
VICL
1.05
+0.01
+0.48%
VOLC
17.97
+0.01
+0.03%
ZGNX
1.32
+0.04
+3.13%
Home » Archive by Category

Xconomy

Coelacanths And Other IPO Thoughts Before The Autumn Markets Return

August 26, 2014 – 6:48 am | Edit Post
Coelacanths And Other IPO Thoughts Before The Autumn Markets Return

Ah, the final week of summer. Would that it could go on forever. And thanks for reading this on your mobile device with your toes in the sand. Just don’t forget to take a dip or toss a Frisbee…

[[Click headline to continue reading.]]

Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis?

August 25, 2014 – 7:03 am | Edit Post
Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis?

Swiss pharmaceutical giant Roche said Sunday it would buy Intermune (NASDAQ: ITMN) of Brisbane, CA, for $8.3 billion. It’s by far the high water mark of a growing wave in recent years of deals…

[[Click headline to continue reading.]]

Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis?

August 25, 2014 – 7:03 am | Edit Post
Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis?

Swiss pharmaceutical giant Roche said Sunday it would buy Intermune (NASDAQ: ITMN) of Brisbane, CA, for $8.3 billion. It’s by far the high water mark of a growing wave in recent years of deals…

[[Click headline to continue reading.]]

BioKier Takes a Shot at a New Kind of Diabetes Drug

August 25, 2014 – 4:00 am | Edit Post
BioKier Takes a Shot at a New Kind of Diabetes Drug

Diabetics know all too well that needle sticks are a routine part of managing their disease. Insulin injections have been part of the diabetes standard of care for decades. And in recent years, a new…

[[Click headline to continue reading.]]

BioKier Takes a Shot at a New Kind of Diabetes Drug

August 25, 2014 – 4:00 am | Edit Post
BioKier Takes a Shot at a New Kind of Diabetes Drug

Diabetics know all too well that needle sticks are a routine part of managing their disease. Insulin injections have been part of the diabetes standard of care for decades. And in recent years, a new…

[[Click headline to continue reading.]]

Biotech Unveils Drug for Viral Infections Tied to Cervical Cancer

August 22, 2014 – 4:00 am | Edit Post
Biotech Unveils Drug for Viral Infections Tied to Cervical Cancer

A small San Diego biotech has identified a drug that appears to prevent several subtypes of the human papillomavirus (HPV) from replicating—including the two HPV subtypes that cause 70 percent…

[[Click headline to continue reading.]]

Biotech Unveils Drug for Viral Infections Tied to Cervical Cancer

August 22, 2014 – 4:00 am | Edit Post
Biotech Unveils Drug for Viral Infections Tied to Cervical Cancer

A small San Diego biotech has identified a drug that appears to prevent several subtypes of the human papillomavirus (HPV) from replicating—including the two HPV subtypes that cause 70 percent…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Ebola, Mapp, Tekmira, ViaCyte & More

August 21, 2014 – 11:09 am | Edit Post
West Coast Biotech Roundup: Ebola, Mapp, Tekmira, ViaCyte & More

Big news this morning: two Americans treated with an experimental Ebola treatment have recovered and are now out of the hospital. (A third person, a Spaniard, who received the treatment unfortunately…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Ebola, Mapp, Tekmira, ViaCyte & More

August 21, 2014 – 11:09 am | Edit Post
West Coast Biotech Roundup: Ebola, Mapp, Tekmira, ViaCyte & More

Big news this morning: two Americans treated with an experimental Ebola treatment have recovered and are now out of the hospital. (A third person, a Spaniard, who received the treatment unfortunately…

[[Click headline to continue reading.]]

Sanford-Burnham Seeks Improved Pharma Ties with New CEO from GSK

August 19, 2014 – 5:02 pm | Edit Post
Sanford-Burnham Seeks Improved Pharma Ties with New CEO from GSK

Following an executive search that took about 18 months, San Diego’s Sanford-Burnham Medical Research Institute named a new CEO today. He is Perry Nisen, a pediatric cancer specialist who specialized…

[[Click headline to continue reading.]]